Endoscopic lithotripsy combined with drug lithotripsy vs. drug lithotripsy for the treatment of phytobezoars: analysis of 165 cases.

Drug lithotripsy Endoscopic lithotripsy Phytobezoar Sodium bicarbonate

Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
08 Apr 2024
Historique:
received: 03 10 2023
accepted: 28 01 2024
medline: 8 4 2024
pubmed: 8 4 2024
entrez: 8 4 2024
Statut: aheadofprint

Résumé

To analyze efficacy of endoscopic lithotripsy combined with drug lithotripsy as compared with drug lithotripsy for the treatment of phytobezoars. We collected and evaluated case records of 165 patients with phytobezoars from 2014 to 2023. And we analyzed demographic and clinical characteristics, imaging features, endoscopic features, complications of phytobezoars, and compared efficacy between endoscopic lithotripsy combined with drug lithotripsy (Group A) and drug lithotripsy (sodium bicarbonate combined with proton pump inhibitor) (Group B). The median age of patients with phytobezoars was 67.84 ± 4.286 years old. Abdominal pain was the most common symptom and peptic ulcers (67.5%) were the most common complication. Bezoar-induced ulcers were more frequent in the gastric angle. The success rate of phytobezoars vanishing in Group A and Group B were similar (92.3% vs. 85.1% within 48 h, 98.7% vs. 97.7% within a week), while the average hospitalization period, average hospitalization cost, second endoscopy rate, and average endoscopic operation time were significantly lower in patients in Group B than in Group A. Drug lithotripsy is the preferred effective and safe treatment option for phytobezoars. We advise that an endoscopy should be completed after 48 h for drug lithotripsy.

Identifiants

pubmed: 38587640
doi: 10.1007/s00464-024-10741-x
pii: 10.1007/s00464-024-10741-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Robles R, Parrilla P, Escamilla C, Lujan JA, Torralba JA, Liron R, Moreno A (1994) Gastrointestinal bezoars. Br J Surg 81(7):1000–1001. https://doi.org/10.1002/bjs.1800810723
doi: 10.1002/bjs.1800810723 pubmed: 7922045
Kement M, Ozlem N, Colak E, Kesmer S, Gezen C, Vural S (2012) Synergistic effect of multiple predisposing risk factors on the development of bezoars. World J Gastroenterol 18(9):960–964. https://doi.org/10.3748/wjg.v18.i9.960
doi: 10.3748/wjg.v18.i9.960 pubmed: 22408356 pmcid: 3297056
Tondreau RL, Kirklin BR (1950) Bezoars of the stomach. Surg Clin North Am 30(4):1097–1108. https://doi.org/10.1016/s0039-6109(16)33091-2
doi: 10.1016/s0039-6109(16)33091-2 pubmed: 15442871
Guner A, Kahraman I, Aktas A, Kece C, Reis E (2012) Gastric outlet obstruction due to duodenal bezoar: a case report. Int J Surg Case Rep 3(11):523–525. https://doi.org/10.1016/j.ijscr.2012.07.005
doi: 10.1016/j.ijscr.2012.07.005 pubmed: 22889707 pmcid: 3437390
Akbulut S, Değer KC, Duman M, Yol S (2016) Gastric bezoars. Prz Gastroenterol. 11(1):60–61. https://doi.org/10.5114/pg.2015.55188
doi: 10.5114/pg.2015.55188 pubmed: 27110315 pmcid: 4814539
Gayà J, Barranco L, Llompart A, Reyes J, Obrador A (2002) Persimmon bezoars: a successful combined therapy. Gastrointest Endosc 55(4):581–583. https://doi.org/10.1067/mge.2002.122332 . (PMID: 11923779)
doi: 10.1067/mge.2002.122332 pubmed: 11923779
Eng K, Kay M (2012) Gastrointestinal bezoars: history and current treatment paradigms. Gastroenterol Hepatol 8(11):776–778
Park SE, Ahn JY, Jung HY, Na S, Park SJ, Lim H, Choi KS, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH, Kim JH (2014) Clinical outcomes associated with treatment modalities for gastrointestinal bezoars. Gut Liver. 8(4):400–407. https://doi.org/10.5009/gnl.2014.8.4.400
doi: 10.5009/gnl.2014.8.4.400 pubmed: 25071905 pmcid: 4113045
Liu YP, Wang D, Li ZS (2016) Clinical progress of treatment in bezoar. China J Endosc 22(11):79–82
Liu LN, Wang L, Jia SJ, Wang P (2020) Clinical features, risk factors, and endoscopic treatment of bezoars: a retrospective analysis from a single center in Northern China. Med Sci Monit 7(26):e926539. https://doi.org/10.12659/MSM.926539
doi: 10.12659/MSM.926539
Khan S, Jiang K, Zhu LP, Khan IA, Ullah K, Khan S, Chen X, Wang BM (2019) Upper gastrointestinal manifestation of bezoars and the etiological factors: a literature review. Gastroenterol Res Pract 15(2019):5698532. https://doi.org/10.1155/2019/5698532
doi: 10.1155/2019/5698532
Camilleri M (2007) Clinical practice diabetic gastroparesis. N Engl J Med 356(8):820–829. https://doi.org/10.1056/NEJMcp062614
doi: 10.1056/NEJMcp062614 pubmed: 17314341
Oh SH, Namgung H, Park MH, Park DG (2012) Bezoar-induced small bowel obstruction. J Korean Soc Coloproctol. 28(2):89–93. https://doi.org/10.3393/jksc.2012.28.2.89
doi: 10.3393/jksc.2012.28.2.89 pubmed: 22606648 pmcid: 3349816
Paschos KA, Chatzigeorgiadis A (2019) Pathophysiological and clinical aspects of the diagnosis and treatment of bezoars. Ann Gastroenterol 32(3):224–232. https://doi.org/10.20524/aog.2019.0370
doi: 10.20524/aog.2019.0370 pubmed: 31040619 pmcid: 6479654
Meng Y, Luo XY, Zhou YH et al (2022) Characteristics of clinical and endoscopic findings of phytobezoars: analysis of 77 cases. Chin J Gastroenterol Hepatol 31(7):784–787
Vats M, Ramasamy S, Neogi S, Tudu SK (2017) Ingestion of nine metallic nails with corrosive: what happened next? BMJ Case Rep. https://doi.org/10.1136/bcr-2017-222338
doi: 10.1136/bcr-2017-222338 pubmed: 29167219 pmcid: 5720311
Sun YJ, Liu BC, Cong L et al (2018) Drug and endoscopic therapy in plant gastrolith: analysis of 61 cases. Chin J Gastroenterol Hepatol 27(1):59–61
Kannan NL, Singaraju H, Sim SW (2013) Laparoscopic-assisted removal of gastric trichobezoar: a novel technique to reduce operative complications and time. J Pediatr Surg 48(8):1826–1827. https://doi.org/10.1016/j.jpedsurg.2013.05.069 . (PMID: 23932631)
doi: 10.1016/j.jpedsurg.2013.05.069 pubmed: 23932631
Lin L, Wang C, Wu J, Liu K, Liu H, Wei N, Lin W, Jiang G, Tai W, Su H (2020) Gastric phytobezoars: the therapeutic experience of 63 patients in Northern China. Rev Esp Enferm Dig 112(1):12–15. https://doi.org/10.17235/reed.2019.6400/2019 . (PMID: 31599640)
doi: 10.17235/reed.2019.6400/2019 pubmed: 31599640

Auteurs

Xiao Zheng (X)

Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China.

Bin Qiu (B)

Department of Oncology, Peking University Third Hospital, Beijing, 100191, China.

Xiao-Wei Jin (XW)

Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China. 13910887208@163.com.

Lin-Na Liu (LN)

Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China.

Peng Wang (P)

Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China.

Hai-Jing Yu (HJ)

Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China.

Juan Zhang (J)

Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China.

Wen-Jing Geng (WJ)

Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China.

Rui Wang (R)

Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China.

Hua Liu (H)

Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China.

Classifications MeSH